BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 20535718)

  • 1. The association of functional mitral regurgitation and anemia in patients with non-ischemic dilated cardiomyopathy.
    Tigen K; Karaahmet T; Kirma C; Kilicgedik A; Dundar C; Pala S; Cevik C; Guler A; Gurel E; Basaran Y
    Cardiol J; 2010; 17(3):274-80. PubMed ID: 20535718
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The importance of papillary muscle dyssynchrony in predicting the severity of functional mitral regurgitation in patients with non-ischaemic dilated cardiomyopathy: a two-dimensional speckle-tracking echocardiography study.
    Tigen K; Karaahmet T; Dundar C; Guler A; Cevik C; Basaran O; Kirma C; Basaran Y
    Eur J Echocardiogr; 2010 Sep; 11(8):671-6. PubMed ID: 20237053
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma N-terminal protype-B natriuretic peptide levels in risk assessment of patients with mitral regurgitation secondary to ischemic and nonischemic dilated cardiomyopathy.
    Dini FL; Fontanive P; Conti U; Andreini D; Cabani E; De Tommasi SM
    Am Heart J; 2008 Jun; 155(6):1121-7. PubMed ID: 18513528
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determinants of functional mitral regurgitation severity in patients with ischemic cardiomyopathy versus nonischemic dilated cardiomyopathy.
    Konstantinou DM; Papadopoulou K; Giannakoulas G; Kamperidis V; Dalamanga EG; Damvopoulou E; Parcharidou DG; Karamitsos TD; Karvounis HI
    Echocardiography; 2014; 31(1):21-8. PubMed ID: 23930844
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intraventricular and papillary muscle dyssynchrony is related to the diastolic phase of functional mitral regurgitation in patients with non-ischemic dilated cardiomyopathy.
    Karaahmet T; Tigen K; Dundar C; Cevik C; Guler A; Gurel E; Kirma C
    J Heart Valve Dis; 2011 Mar; 20(2):136-45. PubMed ID: 21560811
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Papillary muscle dyssynchrony as a cause of functional mitral regurgitation in non-ischemic dilated cardiomyopathy patients with narrow QRS complexes.
    Tigen K; Karaahmet T; Gürel E; Cevik C; Otahbachi M; Pala S; Tanalp AC; Mutlu B; Başaran Y
    Anadolu Kardiyol Derg; 2009 Jun; 9(3):196-203. PubMed ID: 19520653
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diastolic dysfunction and left atrial enlargement as contributing factors to functional mitral regurgitation in dilated cardiomyopathy: data from the Acorn trial.
    Park SM; Park SW; Casaclang-Verzosa G; Ommen SR; Pellikka PA; Miller FA; Sarano ME; Kubo SH; Oh JK
    Am Heart J; 2009 Apr; 157(4):762.e3-10. PubMed ID: 19332207
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reverse remodeling and the mechanism of mitral regurgitation improvement in patients with dilated cardiomyopathy.
    Kuperstein R; Blechman I; Ben Zekry S; Klempfner R; Freimark D; Arad M
    Cardiol J; 2015; 22(4):391-6. PubMed ID: 26235209
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atrial function as a guide to timing of intervention in mitral valve prolapse with mitral regurgitation.
    Ring L; Rana BS; Wells FC; Kydd AC; Dutka DP
    JACC Cardiovasc Imaging; 2014 Mar; 7(3):225-32. PubMed ID: 24529886
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic utility of anemia and pro-B-type natriuretic peptide in patients with nonischemic dilated cardiomyopathy and normal renal function.
    Tigen K; Karaahmet T; Cevik C; Gurel E; Mutlu B; Basaran Y
    Am J Med Sci; 2009 Feb; 337(2):109-15. PubMed ID: 19214026
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recurrence of functional mitral regurgitation in patients with dilated cardiomyopathy undergoing mitral valve repair: how to predict it.
    Digiammarco G; Liberi R; Giancane M; Canosa C; Gallina S; Di Francesco A; Spira G; Di Mauro M
    Interact Cardiovasc Thorac Surg; 2007 Jun; 6(3):340-4. PubMed ID: 17669861
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated uric acid and functional mitral regurgitation in dilated cardiomyopathy.
    Yazicioğlu MV; Avci A; Açar G; Esen Ö; Karaca O; Alici G; Özkan B; Alizade E; Bulut M; Akçakoyun M; Esen AM
    Eur Rev Med Pharmacol Sci; 2012 Nov; 16(12):1637-41. PubMed ID: 23161034
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Quantitative evaluation of functional mitral insufficiency in dilated cardiomyopathy: morphological and functional correlations].
    Gianfaldoni ML; Venturi F; Petix NR; Cecchi A; Monopoli A; Taiti A; Mazzoni V; Bini A
    Ital Heart J Suppl; 2002 Jul; 3(7):738-45. PubMed ID: 12187634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differences in echocardiographic characteristics of functional mitral regurgitation in ischaemic versus idiopathic dilated cardiomyopathy: a pilot study.
    Papadopoulou K; Giannakoulas G; Karvounis H; Dalamanga E; Karamitsos T; Parcharidou D; Damvopoulou E; Efthimiadis GK; Styliadis I; Parcharidis G
    Hellenic J Cardiol; 2009; 50(1):37-44. PubMed ID: 19196619
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relation of N-terminal pro-B-type natriuretic peptide to symptoms, severity, and left ventricular remodeling in patients with organic mitral regurgitation.
    Potocki M; Mair J; Weber M; Hamm C; Burkard T; Hiemetzberger R; Peters K; Jander N; Cron TA; Hess N; Hoffmann A; Gekeler H; Gohlke-Bärwolf C; Buser P; Mueller C
    Am J Cardiol; 2009 Aug; 104(4):559-64. PubMed ID: 19660612
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantification of left ventricular interstitial fibrosis in asymptomatic chronic primary degenerative mitral regurgitation.
    Edwards NC; Moody WE; Yuan M; Weale P; Neal D; Townend JN; Steeds RP
    Circ Cardiovasc Imaging; 2014 Nov; 7(6):946-53. PubMed ID: 25140067
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tenting area reflects disease severity and prognosis in patients with non-ischaemic dilated cardiomyopathy and functional mitral regurgitation.
    Karaca O; Avci A; Guler GB; Alizade E; Guler E; Gecmen C; Emiroglu Y; Esen O; Esen AM
    Eur J Heart Fail; 2011 Mar; 13(3):284-91. PubMed ID: 21106544
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determinants of regurgitant volume in mitral regurgitation: contrasting effect of similar effective regurgitant orifice area in functional and organic mitral regurgitation.
    Chiampan A; Nahum J; Leye M; Oziel J; Cueff C; Brochet E; Iung B; Rossi A; Vahanian A; Messika-Zeitoun D
    Eur Heart J Cardiovasc Imaging; 2012 Apr; 13(4):324-9. PubMed ID: 22101150
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between native papillary muscle T
    Kato S; Nakamori S; Roujol S; Delling FN; Akhtari S; Jang J; Basha T; Berg S; Kissinger KV; Goddu B; Manning WJ; Nezafat R
    J Cardiovasc Magn Reson; 2016 Nov; 18(1):79. PubMed ID: 27846845
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Independent prognostic value of functional mitral regurgitation in patients with heart failure. A quantitative analysis of 1256 patients with ischaemic and non-ischaemic dilated cardiomyopathy.
    Rossi A; Dini FL; Faggiano P; Agricola E; Cicoira M; Frattini S; Simioniuc A; Gullace M; Ghio S; Enriquez-Sarano M; Temporelli PL
    Heart; 2011 Oct; 97(20):1675-80. PubMed ID: 21807656
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.